Allianz Asset Management
BMRN icon

Allianz Asset Management’s BioMarin Pharmaceuticals BMRN Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$1.31M Sell
23,841
-13,026
-35% -$716K ﹤0.01% 1208
2025
Q1
$2.61M Buy
36,867
+8,252
+29% +$583K ﹤0.01% 1062
2024
Q4
$1.88M Buy
28,615
+1,782
+7% +$117K ﹤0.01% 1123
2024
Q3
$1.89M Sell
26,833
-55
-0.2% -$3.87K ﹤0.01% 1122
2024
Q2
$2.21M Buy
26,888
+5,330
+25% +$439K ﹤0.01% 1054
2024
Q1
$1.88M Sell
21,558
-16,486
-43% -$1.44M ﹤0.01% 1070
2023
Q4
$3.67M Sell
38,044
-6,807
-15% -$656K 0.01% 870
2023
Q3
$3.97M Sell
44,851
-2,832
-6% -$251K 0.01% 824
2023
Q2
$4.13M Buy
47,683
+1,092
+2% +$94.7K 0.01% 754
2023
Q1
$4.53M Buy
46,591
+23
+0% +$2.24K 0.01% 812
2022
Q4
$4.82M Sell
46,568
-2,886
-6% -$299K 0.01% 782
2022
Q3
$4.19M Sell
49,454
-45,053
-48% -$3.82M 0.01% 828
2022
Q2
$7.83M Buy
94,507
+27,559
+41% +$2.28M 0.01% 923
2022
Q1
$5.16M Buy
66,948
+69
+0.1% +$5.32K ﹤0.01% 1086
2021
Q4
$5.92M Buy
66,879
+5,930
+10% +$524K ﹤0.01% 1071
2021
Q3
$4.71M Buy
60,949
+6,832
+13% +$528K ﹤0.01% 1117
2021
Q2
$4.52M Sell
54,117
-215,347
-80% -$18M ﹤0.01% 1061
2021
Q1
$20.3M Sell
269,464
-22,900
-8% -$1.73M 0.02% 595
2020
Q4
$25.6M Buy
292,364
+95,801
+49% +$8.4M 0.03% 526
2020
Q3
$15M Sell
196,563
-164,040
-45% -$12.5M 0.02% 643
2020
Q2
$44.5M Buy
360,603
+63,737
+21% +$7.86M 0.05% 340
2020
Q1
$25.1M Sell
296,866
-61,578
-17% -$5.2M 0.03% 436
2019
Q4
$30.3M Sell
358,444
-132,434
-27% -$11.2M 0.03% 517
2019
Q3
$33.1M Buy
490,878
+3,924
+0.8% +$265K 0.03% 512
2019
Q2
$41.7M Sell
486,954
-47,853
-9% -$4.1M 0.04% 443
2019
Q1
$47.5M Buy
534,807
+24,984
+5% +$2.22M 0.05% 387
2018
Q4
$43.3M Buy
509,823
+37,560
+8% +$3.19M 0.05% 366
2018
Q3
$45.8M Buy
472,263
+14,912
+3% +$1.45M 0.04% 403
2018
Q2
$43.1M Buy
457,351
+12,542
+3% +$1.18M 0.04% 390
2018
Q1
$36.1M Sell
444,809
-12,726
-3% -$1.03M 0.03% 485
2017
Q4
$40.8M Sell
457,535
-8,000
-2% -$713K 0.03% 438
2017
Q3
$43.3M Sell
465,535
-104,981
-18% -$9.77M 0.04% 399
2017
Q2
$51.6M Sell
570,516
-41,014
-7% -$3.71M 0.05% 345
2017
Q1
$53.8M Buy
611,530
+37,162
+6% +$3.27M 0.05% 339
2016
Q4
$47.6M Sell
574,368
-59,246
-9% -$4.91M 0.04% 389
2016
Q3
$58.7M Sell
633,614
-35,132
-5% -$3.25M 0.06% 286
2016
Q2
$52M Buy
668,746
+55,885
+9% +$4.35M 0.06% 305
2016
Q1
$50.5M Buy
612,861
+357,156
+140% +$29.5M 0.06% 320
2015
Q4
$26.9M Buy
255,705
+20,125
+9% +$2.12M 0.03% 549
2015
Q3
$24.8M Buy
235,580
+8,395
+4% +$884K 0.03% 568
2015
Q2
$31.1M Sell
227,185
-12,931
-5% -$1.77M 0.03% 543
2015
Q1
$29.9M Sell
240,116
-19,250
-7% -$2.4M 0.03% 491
2014
Q4
$23.4M Buy
259,366
+107,288
+71% +$9.7M 0.03% 565
2014
Q3
$11M Sell
152,078
-9,505
-6% -$686K 0.01% 741
2014
Q2
$10.1M Sell
161,583
-9,450
-6% -$588K 0.01% 726
2014
Q1
$11.7M Buy
171,033
+39,049
+30% +$2.66M 0.01% 705
2013
Q4
$9.28M Sell
131,984
-199,916
-60% -$14.1M 0.01% 748
2013
Q3
$24M Buy
331,900
+232,300
+233% +$16.8M 0.03% 467
2013
Q2
$5.55M Buy
+99,600
New +$5.55M 0.01% 849